Moses Makunje
Director of Finance/CFO bei NUVATION BIO INC.
Vermögen: 38 628 $ am 31.03.2024
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| David Hung | M | 66 | 6 Jahre | |
| Kim Blickenstaff | M | 71 | 5 Jahre | |
| Kathryn Falberg | F | 63 | 4 Jahre | |
| Robert D. Mashal | M | - | - | |
| Tony Vernon | M | 68 | 5 Jahre | |
| Robert B. Bazemore | M | 56 | 4 Jahre | |
| Jonathan Lim | M | 52 |
Maze Therapeutics, Inc.
 Maze Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Maze Therapeutics, Inc. is a is a biopharmaceutical company, which engages in the development of portfolio of therapeutic candidates for a number of genetically defined diseases. It focuses on translating genetic insights into new medicines by utilizing an approach that combines the analysis of large-scale human genetics data, cutting-edge functional genomics, and an array of drug discovery approaches. The company was founded by Mark Daly, Aaron D. Gitler, Stephen Elledge, Sekar Kathiresan, and Jonathan S. Weissman in 2018 and is headquartered in San Francisco, CA. | 5 Jahre |
| Kerry Wentworth | F | 51 | 2 Jahre | |
| Daniel Welch | M | 66 | 4 Jahre | |
| Richard Scheller | M | 70 |
Maze Therapeutics, Inc.
Maze Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Maze Therapeutics, Inc. is a is a biopharmaceutical company, which engages in the development of portfolio of therapeutic candidates for a number of genetically defined diseases. It focuses on translating genetic insights into new medicines by utilizing an approach that combines the analysis of large-scale human genetics data, cutting-edge functional genomics, and an array of drug discovery approaches. The company was founded by Mark Daly, Aaron D. Gitler, Stephen Elledge, Sekar Kathiresan, and Jonathan S. Weissman in 2018 and is headquartered in San Francisco, CA. | 5 Jahre |
| Gary Hattersley | M | 57 | 5 Jahre | |
| Stacy Markel | F | 59 | 5 Jahre | |
| David Hanley | M | 54 | 3 Jahre | |
| Dong Fang Liu | M | 54 | 2 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Oleg Nodelman | M | 47 | 2 Jahre | |
| Jennifer Fox | F | 53 | 3 Jahre | |
| Lisa V. DeLuca | M | - | - | |
| Thomas S. Templeman | M | 64 | 2 Jahre | |
| Sergey Yurasov | M | 55 | 3 Jahre | |
| Michelle Doig | F | 50 | 2 Jahre | |
| Alex Colville | M | - |
Maze Therapeutics, Inc.
Maze Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Maze Therapeutics, Inc. is a is a biopharmaceutical company, which engages in the development of portfolio of therapeutic candidates for a number of genetically defined diseases. It focuses on translating genetic insights into new medicines by utilizing an approach that combines the analysis of large-scale human genetics data, cutting-edge functional genomics, and an array of drug discovery approaches. The company was founded by Mark Daly, Aaron D. Gitler, Stephen Elledge, Sekar Kathiresan, and Jonathan S. Weissman in 2018 and is headquartered in San Francisco, CA. | 1 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 21 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Moses Makunje
- Persönliches Netzwerk
